Evidence-based review of the utility of radiation therapy in the treatment of endometrial cancer.
Endometrial cancer is the most common cancer of the female genital tract in the USA and usually presents at an early stage. Most women are cured with surgery, however, some patients may require adjuvant therapy including radiation and/or chemotherapy. Risk factors determine the need for adjuvant treatment and, based on these risk factors, patients are categorized as being at low, intermediate or high risk for recurrence. In this article we will review the best level of evidence available for the use of radiation therapy within each risk stratum. The most controversy and debate is associated with patients stratified to the intermediate-risk group.
Dewdney
S B
SB
Department of Obstetrics & Gynecology, Washington University School of Medicine and Siteman Cancer Center, St Louis, MO 63110, USA. dewdneys@wustl.edu
Mutch
D G
DG
D002986:Clinical Trials as Topic; D016889:Endometrial Neoplasms / Q000532:radiotherapy* / Q000601:surgery; D019317:Evidence-Based Medicine; D005260:Female; D006801:Humans; D009367:Neoplasm Staging; D012307:Risk Factors